
Mezzanine Management sells Optimapharm to Rohatyn Group
Mezzanine Management has sold Croatian contract research organisation Optimapharm to asset management firm The Rohatyn Group (TRG).
Latest News
Bid Equity's Myneva bolts on Patronis, TTS
Social care and healthcare software platform is following a buy-and-build strategy
Palatine backs Anthesis
Company intends to further boost its growth both organically and via strategic acquisitions
Agilitas 2020 Private Equity closes on €565m
Fund focuses on mid-market companies across western Europe, within a range of sectors
Apax sells Sandaya to InfraVia
Sale ends a five-year holding period for Apax, which acquired a majority stake in Sandaya from Pragma Capital
Back to Top